CASE Op-ed – Issues & Insights: The Terrible, Horrible, No Good, Very Bad Day For American Patients
Gerard Scimeca – Chairman, CASE August 7, 2020 Late last month the Trump administration delivered a blow to American patients...
Forced Mail-Order Pharmacies: Unfair to Patients and Wasteful
For most Americans, picking up a prescription is a routine ordeal. Though costs and co-pays can vary greatly, most...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/